These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 1680148

  • 41. Use of perfluorochemical emulsions in cancer therapy.
    Teicher BA.
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):875-82. PubMed ID: 1391527
    [Abstract] [Full Text] [Related]

  • 42. Fluosol-DA in radiation therapy.
    Lustig RA, McIntosh NL.
    Prog Clin Biol Res; 1986; 211():29-38. PubMed ID: 3960931
    [No Abstract] [Full Text] [Related]

  • 43. Antipyrine kinetics following partial blood exchange with Fluosol-DA in the rat.
    Shrewsbury RP, White SG, Pollack GM, Wargin WA.
    J Pharm Pharmacol; 1986 Dec; 38(12):883-7. PubMed ID: 2880960
    [Abstract] [Full Text] [Related]

  • 44. Effect of a perfluorochemical emulsion on the rat hepatic mixed function oxidase system.
    Ravis WR, Ramakanth S, Brzozowski DM, Hamrick ME.
    J Pharm Pharmacol; 1992 Mar; 44(3):219-23. PubMed ID: 1354727
    [Abstract] [Full Text] [Related]

  • 45. Lack of complications in long-term survivors after treatment with Fluosol and oxygen as an adjuvant to radiation therapy for high-grade brain tumors.
    Evans RG, Kimler BF, Morantz RA, Batnitzky S.
    Int J Radiat Oncol Biol Phys; 1993 Jul 15; 26(4):649-52. PubMed ID: 8330996
    [Abstract] [Full Text] [Related]

  • 46. Present status of clinical studies of Fluosol-DA (20%) in Japan.
    Mitsuno T, Ohyanagi H.
    Int Anesthesiol Clin; 1985 Jul 15; 23(1):169-84. PubMed ID: 3980104
    [Abstract] [Full Text] [Related]

  • 47. Effects of a perfluorochemical emulsion on the response of BA1112 rat rhabdomyosarcomas to continuous low-dose-rate irradiation.
    Morton JD, Porter E, Yabuki H, Nath R, Rockwell S.
    Radiat Res; 1990 Nov 15; 124(2):178-82. PubMed ID: 2123353
    [Abstract] [Full Text] [Related]

  • 48. Acute effects of a perfluorochemical oxygen carrier on normal tissues of the mouse.
    Mason KA, Withers HR, Steckel RJ.
    Radiat Res; 1985 Dec 15; 104(3):387-94. PubMed ID: 4080982
    [Abstract] [Full Text] [Related]

  • 49. Effect of fluosol-DA infusion on pulmonary vascular permeability in the dog lung.
    Hall JE, Ehrhart IC, Hofman WF.
    J Trauma; 1986 May 15; 26(5):432-7. PubMed ID: 3084806
    [Abstract] [Full Text] [Related]

  • 50. Enhancement of tumor radiation response by the combination of a perfluorochemical emulsion and hyperbaric oxygen.
    Martin DF, Porter EA, Rockwell S, Fischer JJ.
    Int J Radiat Oncol Biol Phys; 1987 May 15; 13(5):747-51. PubMed ID: 3570898
    [Abstract] [Full Text] [Related]

  • 51. Extracorporeal circulation with perfluorochemicals (Fluosol-DA).
    Hoshino S, Iwaya F, Igari T, Kanno M, Honda K.
    J Cardiovasc Surg (Torino); 1982 May 15; 23(6):463-9. PubMed ID: 7153234
    [Abstract] [Full Text] [Related]

  • 52. The effect of varying extents of Fluosol-DA or normal saline haemodilution on the dose dependent kinetics of phenytoin in the rat.
    Shrewsbury RP, Oliver SR, Lewis LM, Anderson WT, White LG.
    J Pharm Pharmacol; 1989 Aug 15; 41(8):582-4. PubMed ID: 2571710
    [Abstract] [Full Text] [Related]

  • 53. Surgical use of fluosol-DA in Jehovah's Witness patients.
    Ohyanagi H, Nakaya S, Okumura S, Saitoh Y.
    Artif Organs; 1984 Feb 15; 8(1):10-8. PubMed ID: 6703920
    [Abstract] [Full Text] [Related]

  • 54. Experimental studies on fluosol DA administration in acute pancreatitis.
    Ohyanagi H, Ohashi O, Nakayama S, Yamamoto M, Okumura S, Saitoh Y.
    Biomater Artif Cells Artif Organs; 1988 Feb 15; 16(1-3):585-94. PubMed ID: 3179491
    [Abstract] [Full Text] [Related]

  • 55. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%) on cerebral circulation in the monkey.
    Nagasawa S, Handa H, Naruo Y, Oda Y, Yonekawa Y, Takebe Y.
    Neurol Res; 1981 Feb 15; 3(3):237-50. PubMed ID: 6122175
    [Abstract] [Full Text] [Related]

  • 56. The effect of moderate haemodilution with Fluosol-DA or Hespan on the nonmicrosomal acetylation of sulphadimidine in the rat.
    Shrewsbury RP, Hong DD, White LG, Gordon TR.
    J Pharm Pharmacol; 1992 Feb 15; 44(2):84-8. PubMed ID: 1378493
    [Abstract] [Full Text] [Related]

  • 57. Prevention of neutrophil-mediated injury to endothelial cells by perfluorochemical.
    Babbitt DG, Forman MB, Jones R, Bajaj AK, Hoover RL.
    Am J Pathol; 1990 Feb 15; 136(2):451-9. PubMed ID: 2407126
    [Abstract] [Full Text] [Related]

  • 58. Effect of Fluosol-DA and hetastarch on local cerebral blood flow, cortical O2 availability and computerized EEG data during cerebral ischaemia.
    Tranmer BI, Iacobacci R, Feiler S.
    Neurol Res; 1990 Mar 15; 12(1):17-22. PubMed ID: 1692110
    [Abstract] [Full Text] [Related]

  • 59. Protective effect of Fluosol-DA in acute cerebral ischemia.
    Peerless SJ, Ishikawa R, Hunter IG, Peerless MJ.
    Stroke; 1981 Mar 15; 12(5):558-63. PubMed ID: 6795765
    [Abstract] [Full Text] [Related]

  • 60. Preclinical studies of a perfluorochemical emulsion as an adjunct to radiotherapy.
    Rockwell S, Irvin CG, Kelley M.
    Int J Radiat Oncol Biol Phys; 1988 Oct 15; 15(4):913-20. PubMed ID: 3141320
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.